Developing a tumor targeting nanocarrier with NIR-light triggered drug release capabilities and evaluating its efficacy in 3D microtumor models. Investigating the interactions between nanocarriers and cancerous cells in 3D tumor microenvironments using live 3D imaging. Developing tunable, dual T1 MRI and fluorescent imaging probes for whole animal imaging. Advised by Dr. Stefan Chassaing.
Novartis Research Center Basel, Switzerland
Formulated nanosuspensions of hydrophobic active pharmaceutical ingredients for oral and parenteral delivery. Investigated process parameters relating to formulation stability and developed a thermodynamic model to predict the stability of nanosuspensions. Developed a novel hydrophobic ion pairing formulation approach to enable the encapsulation of weakly hydrophobic, ionizable molecules into nanoparticles. Advised by Dr. Bernd Riebesehl, Dr. Jörg Brozio and Dr. Andreas Fisch. Summer 2011 "Initiated chemical vapor deposition (iCVD) of conformal polymeric nanocoatings for the surface modification of high aspect ratio pores," M. Gupta, V. Kapur, N.M. Pinkerton, and K.K. Gleason, Chem. Mater. 2008 , 20, 1646 
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